This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castonguay, A. Articles by Hecht, S. S. Search for Related Content PubMed PubMed Citation Articles by Castonguay, A. Articles by Hecht, S. S.

Tissue Distribution of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Its Metabolites in F344 Rats^{1, 2,}

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595 [A. C., S. S. H.], and Department of Toxicology, University of Uppsala, S-751 23 Uppsala, Sweden [H. T.]

³ To whom requests for reprints should be addressed.

The tissue distribution of the tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the F344 rat was studied by whole-body autoradiography and high-performance liquid chromatography. The results of the wholebody autoradiography experiments indicate that the substance is able to freely cross biological membranes and reach all tissues of the body. A high level of tissue-bound metabolites occurred in the mucosa of the ethmoturbinates, in the lung, and the liver, which are the targets for the carcinogenicity of NNK in F344 rats. However, tissue-bound radioactivity was also present in non-target tissues such as the lateral nasal gland (Steno's gland), the tracheal mucosa, and the mucosa of the nasopharyngeal duct. A high level of unbound radioactivity occurred in the preputial gland, submaxillary and adrenal glands, and the urinary and gastrointestinal systems. High localization of unbound radioactivity was observed in the stomach lumen not only after p.o. but also after i.v. administration of NNK. Analysis of extracts of the stomach contents by high-performance liquid chromatography indicated that, due to their basicity, NNK and its metabolites were trapped in the gastric juice and later reabsorbed from the intestinal tract. Analysis of unbound metabolites in various tissues and in the urine after i.v. or p.o. administration of [carbonyl-¹⁴C]NNK indicated metabolism and excretion of products resulting from -carbon hydroxylation, carbonyl reduction, and pyridine N-oxidation of NNK. After p.o. administration of [¹⁴CH₃]NNK, 47% of the dose was recovered as ¹⁴CO₂. [carbonyl-¹⁴C]NNK, however, was not metabolized to ¹⁴CO₂. Levels of in vitro metabolism of [¹⁴CH₃]-NNK to ¹⁴CO₂ or incorporation of radioactivity into the acid-insoluble material after incubation with [carbonyl-¹⁴C]NNK were the highest in the nasal mucosa. Thus, the high activity of NNK-activating enzymes present in the nasal cavity is apparently an important factor in the etiology of NNK-induced neuroepitheliomas. In vitro autoradiography experiments showed that NNK is metabolized in the mucosa of the ethmoturbinates, the lung, and the liver, suggesting that the tumors are induced by metabolites formed locally in the target tissues. In the lung, the labeling was higher in the bronchial tree than in the lung parenchyma.

¹ This study was supported by the National Cancer Institute Grant 21393 and a Swedish Government Grant. This is Paper 48 in the series, "A Study of Chemical Carcinogenesis."

² This study is dedicated to the founder of the American Health Foundation, Dr. Ernst L. Wynder, on the occasion of the 10th anniversary of the Naylor Dana Institute for Disease Prevention.

Received 2/16/82. Accepted 10/28/82.

This article has been cited by other articles:

				M. Miyazaki, H. Yamazaki, H. Takeuchi, K. Saoo, M. Yokohira, K.-i. Masumura, T. Nohmi, Y. Funae, K. Imaida, and T. Kamataki Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas Carcinogenesis, November 1, 2005; 26(11): 1947 - 1955. [Abstract] [Full Text] [PDF]

				X. Zhuo, J. Gu, M. J. Behr, P. J. Swiatek, H. Cui, Q.-Y. Zhang, Y. Xie, D. N. Collins, and X. Ding Targeted Disruption of the Olfactory Mucosa-Specific Cyp2g1 Gene: Impact on Acetaminophen Toxicity in the Lateral Nasal Gland, and Tissue-Selective Effects on Cyp2a5 Expression J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 719 - 728. [Abstract] [Full Text] [PDF]

				Z. Wu, P. Upadhyaya, S. G. Carmella, S. S. Hecht, and C. L. Zimmerman Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution Carcinogenesis, January 1, 2002; 23(1): 171 - 179. [Abstract] [Full Text] [PDF]

				T. Koujitani, K. Yasuhara, K. Toyosawa, A. Shimada, H. Onodera, H. Takagi, T. Tamura, M. Hirose, and K. Mitsumori Immunohistochemical and Ultrastructural Studies of 2,6-Dimethylaniline-induced Nasal Proliferative Lesions in a Rat Two-stage Nasal Carcinogenesis Model Initiated with N-bis(2-hydroxypropyl)nitrosamine Toxicol Pathol, April 1, 2001; 29(3): 300 - 307. [Abstract] [PDF]

				M. Meger, E. Richter, W. Zwickenpflug, C. Oehlmann, M. B. Hargaden, Y. I. A-Rahim, and E. S. Vesell Metabolism and Disposition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Rhesus Monkeys Drug Metab. Dispos., April 1, 1999; 27(4): 471 - 478. [Abstract] [Full Text]

				S. S. Hecht, S. G. Carmella, M. Chen, J. F. D. Koch, A. T. Miller, S. E. Murphy, J. A. Jensen, C. L. Zimmerman, and D. K. Hatsukami Quantitation of Urinary Metabolites of a Tobacco-specific Lung Carcinogen after Smoking Cessation Cancer Res., February 1, 1999; 59(3): 590 - 596. [Abstract] [Full Text] [PDF]